NHS: brick walls to innovation and £30m savings


26th July 2016

65m urine specimens are taken every year on the NHS … without a defined protocol. Mixed growth rates (unreliable specimens) vary from 1.4% to over 73% nationwide, calling for an established protocol to give this essential diagnostic procedure parity with blood, taken for the same purpose. MedTechEngine writes about the long and winding road experienced by Forte Medical in selling its Peezy Midstream innovation to the NHS. Read all about it at MedTech Engine